- Groton CT, US Xiao HU - Ballwin MO, US Kevin D. JEROME - St. Charles MO, US Mark G. OBUKOWICZ - Kirkwood MO, US Lisa Maria OLSON - Hopkinton MA, US Paul V. RUCKER - Carlsbad CA, US Ronald Keith WEBBER - St. Peters MO, US
Assignee:
Pfizer Inc. - Groton CT
International Classification:
C07D 213/89
US Classification:
546285
Abstract:
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Hengmiao (Henry) CHENG - San Diego CA, US Xiao HU - Ballwin MO, US Kenvin D. JEROME - St. Charles MO, US Mark OBUKOWICZ - Kirkwood MO, US Lisa OLSON - Hopkinton MA, US Paul V. RUCKER - Carlsbad CA, US Ronald Keith WEBBER - St. Peters MO, US
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Hengmiao (Henry) Cheng - San Diego CA, US Xiao Hu - Ballwin MO, US Kevin D. Jerome - St.Charles MO, US Mark Obukowicz - Kirkwood MO, US Lisa Olson - Hopkinton MA, US Paul V. Rucker - Carlsbad CA, US Ronald Keith Webber - St. Peters MO, US
Assignee:
Pfizer, Inc. - New York NY
International Classification:
A61K 31/44 C07K 1/113
US Classification:
514352, 530409
Abstract:
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Hengmiao (Henry) Cheng - San Diego CA, US Rajesh Devraj - Chesterfield MO, US Gary A. Decresenzo - St. Charles MO, US Xiao Hu - Ballwin MO, US Kevin D. Jerome - St. Charles MO, US Mark Obukowicz - Kirkwood MO, US Lisa Olson - Hopkinton MA, US Ronald Keith Webber - St. Peters MO, US
Assignee:
Pfizer,Inc. - New York NY
International Classification:
A61K 31/44
US Classification:
514352
Abstract:
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Hengmiao (Henry) Cheng - San Diego CA, US Xiao Hu - Ballwin MO, US Kevin D. Jerome - St. Charles MO, US Mark Obukowicz - Kirkwood MO, US Lisa Olson - Hopkinton MA, US Paul V. Rucker - Carlsbad CA, US Ronald Keith Webber - St. Peters MO, US
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Hengmiao (Henry) Cheng - San Diego CA, US Rajesh Devraj - Chesterfield MO, US Gary A. DeCresenzo - St.Charles MO, US Xiao Hu - St. Charles MO, US Kevin D. Jerome - St.Charles MO, US Mark Obukowicz - Kirkwood MO, US Lisa Olson - Hopkinton MA, US Paul V. Rucker - Carlsbad CA, US Ronald Keith Webber - St.Peters MO, US
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
RTI TRADCO Washington, MO 2006 to 2007 Brake Form OperatorGDX New Haven, MO 1996 to 2006 TechnicianTSI New Haven, MO 1989 to 1993 lead production worker
Dr. Webber graduated from the University of South Florida College of Medicine at Tampa in 1994. He works in Sarasota, FL and specializes in Psychiatry.